Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Screening Protocol for the Evaluation of Research Participants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01036217
Recruitment Status : Completed
First Posted : December 21, 2009
Last Update Posted : July 2, 2017
Information provided by:
National Institutes of Health Clinical Center (CC)

Brief Summary:


- The National Institute on Drug Abuse (NIDA) uses a standardized set of procedures to develop a pool of potential participants for research studies. Because some of the data collected during screening are used later for research, the screening itself is considered a study. An applicant to any NIDA study is considered a participant in NIDA screening.


- To identify, recruit, and screen participants for NIDA research protocols.


- Individuals 18 years of age and older who are able to provide informed consent.


  • Individuals who are eligible for screening will undergo two interviews: a telephone interview and an in-person interview. The phone interview will determine eligibility for the in-person interview.
  • The in-person interview may require up to five visits to NIDA. The in-person visit will involve any or all of the following procedures: (1) full physical examination and medical history; (2) psychiatric interview; (3) psychological testing; (4) electrocardiogram; (5) samples of blood, urine, and hair; and (6) other minimally invasive procedures as directed by the research staff.
  • During screening, a photograph will be taken for confirmation of identity during subsequent visits for other studies.
  • No clinical care will be provided as part of screening.

Condition or disease
Substance Abuse Disorders

Detailed Description:
Through its clinical research protocols, the NIDA IRP attempts to: elucidate the nature of drug abuse and addiction; determine the potential use of new therapies, both pharmacological and psychosocial; and decipher the long-term effects of drugs of abuse on the development, maturation, function, and structure of the brain and other organ systems. In support of the IRP's work, the scientific goal of this screening protocol is to assess potential research participants' eligibility for NIDA IRP research studies. Screening will include medical and psychological tests and procedures. The data collected during screening are a unique and valuable source of information that aids in NIDA's mission. Therefore, a secondary goal of this protocol is to obtain data that characterizes the population of subjects contacting NIDA about research participation and to analyze data so obtained, such as that on the prevalence and consequences of HIV/AIDS, viral hepatitis, and related diseases.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 55000 participants
Time Perspective: Prospective
Official Title: Evaluation of Potential Research Subjects - Screening Protocol for Clinical Studies
Study Start Date : May 17, 2006
Study Completion Date : June 17, 2010

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

    1. Adults (at least age 18)
    2. Ability to understand and answer the questions as posed.


1. Inability to provide valid informed consent.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01036217

Layout table for location information
United States, Maryland
National Institute on Drug Abuse, Biomedical Research Center (BRC)
Baltimore, Maryland, United States, 21224
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
Layout table for additonal information Identifier: NCT01036217    
Other Study ID Numbers: 999906412
First Posted: December 21, 2009    Key Record Dates
Last Update Posted: July 2, 2017
Last Verified: June 17, 2010
Keywords provided by National Institutes of Health Clinical Center (CC):
Additional relevant MeSH terms:
Layout table for MeSH terms
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders